Skip to main content
idi
Toggle navigation
0
You have 0 notifications
Site Visitor
Site Visitor
New To Inknowvation.com?
Register now to get an access to proprietary SBIR-STTR databases!
Registration is fast and free - start your access to business-actionable information today!
Login
Site Register
SBIR-STTR Award
You are here:
Home
Search Databases
Search SBIR-STTR Awards
SBIR-STTR Award
5
Increased Expression of an HIV CJ505.664 SOSIP Envelope in Plants by Modulation of ER Chaperones
Award last edited on: 6/12/20
Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$288,224
Award Phase
1
Solicitation Topic Code
NIAID
Principal Investigator
Yvonne J Rosenberg
Company Information
Plantvax Inc
(
AKA
: Plant Vax Inc)
9430 Key West Avenue #120
Rockville, MD 20850
(240) 453-6247
info@plantvax.com
www.plantvax.com
Location:
Single
Congr. District:
08
County:
Montgomery
Phase I
Contract Number:
75N93019C00010-0-9999-1
Start Date:
00/00/00
Completed:
00/00/00
Phase I year
2019
Phase I Amount
$288,224
The recombinant HIV SOSIP Envelope Env trimer is the leading HIV vaccine candidate but current production levels are low in mammalian cell lines likely due to current trimer designs which include numerous disulfide bonds proteolytic cleavage and extensive glycosylation known to induce endoplasmic reticulum stress and cellular toxicity. This proposal will utilize the Nicotiana benthamiana pN bp plant expression system to produce the CH FR SOSIP Env CHSOSIP and address whether manipulation of ER chaperones will increase the host cell capacity for correct folding disulfide bond formation and post translational modification. Thus the unfolded protein response UPR will be induced by co expressing the master regulators bZIPs and bZIP active forms of transcription factors and selected ER chaperones BiPPDIPPICRT and CNX individually and in combination. The N bp plant platform offers an advantage for rapidly assessing cellular toxicity by phenotypic screening of leaf browning after days. In addition the proposed studies will examine whether fusions between the anti CLEC A antibody and CHSOSIP Env molecules will enhance stability and expression levels as well as provide for a generic protein A based downstream processing strategy. Finally the suitability of a stress resistant plant host. Nicotiana tabacum for producing VHSOSIP Env at a commercial scale will be evaluated
Phase II
Contract Number:
----------
Start Date:
00/00/00
Completed:
00/00/00
Phase II year
----
Phase II Amount
----
×
Login to your account
Mail sent successfully.
Enter any username and password.
Username
Password
Remember me
Login
Forgot your username?
Click here for assistance
Forgot your password?
Request new password
Don't have an account?
Sign up
Forgot username?
Mail sent successfully.
Enter username and password.
Please enter email address that is associated with your account.
Back
Submit
Still Need Help?
If you need further assistance, send us an
e-mail
and we will assist you in resetting your account.
Forgot password?
Mail sent successfully.
Enter username and password.
Please enter email address that is associated with your account.
Back
Submit
Still Need Help?
If you need further assistance, send us an
e-mail
and we will assist you in resetting your account.